Noon Capital Launches with a Bold Promise: Smarter Yields, Fairer Returns, and Transparent Staking for All
ROAD TOWN, British Virgin Islands, May 07, 2025 (GLOBE NEWSWIRE) -- Noon…
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
Data suggest BP1001-A prevents fatty acid-induced insulin resistance in cells May 01,…